Al-Modawat Specialized Medical Company (TADAWUL:9594)

TADAWUL:9594 Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	306	337	404	-	-	-
Market Cap Growth	-27.99%	-16.62%	-	-	-	-
Enterprise Value	326	351	392	-	-	-
Last Close Price	4.30	4.68	5.57	-	-	-
PE Ratio	16.15	17.74	66.48	-	-	-
PS Ratio	2.51	2.76	5.35	-	-	-
PB Ratio	3.47	3.82	5.24	-	-	-
P/TBV Ratio	3.48	3.82	5.25	-	-	-
P/FCF Ratio	160.99	177.04	-	-	-	-
P/OCF Ratio	71.58	78.72	40.11	-	-	-
EV/Sales Ratio	2.68	2.88	5.20	-	-	-
EV/EBITDA Ratio	10.13	12.66	37.78	-	-	-
EV/EBIT Ratio	13.61	14.64	48.76	-	-	-
EV/FCF Ratio	171.70	184.65	-	-	-	-
Debt / Equity Ratio	0.37	0.37	0.21	0.23	0.28	0.41
Debt / EBITDA Ratio	1.01	1.01	1.18	0.36	0.60	5.46
Debt / FCF Ratio	17.08	17.08	-	0.95	3.71	-
Net Debt / Equity Ratio	0.23	0.23	0.01	0.23	0.23	0.06
Net Debt / EBITDA Ratio	0.73	0.73	0.06	0.38	0.53	1.17
Net Debt / FCF Ratio	10.71	10.71	-0.07	0.92	3.11	-0.48
Asset Turnover	0.88	0.88	0.77	1.05	1.03	-
Inventory Turnover	14.60	14.60	10.85	10.99	15.17	-
Quick Ratio	1.36	1.36	1.78	1.13	0.93	0.81
Current Ratio	1.52	1.52	2.03	1.31	1.11	1.01
Return on Equity (ROE)	22.95%	22.95%	10.44%	52.94%	41.03%	-
Return on Assets (ROA)	10.77%	10.77%	5.11%	19.30%	13.30%	-
Return on Invested Capital (ROIC)	21.26%	24.09%	11.43%	48.44%	40.28%	-2.36%
Return on Capital Employed (ROCE)	22.80%	22.80%	8.70%	44.00%	29.10%	-1.50%
Earnings Yield	6.20%	5.64%	1.50%	-	-	-
FCF Yield	0.62%	0.56%	-2.11%	-	-	-
Payout Ratio	15.02%	15.02%	359.81%	50.30%	-	-
Buyback Yield / Dilution	-2.82%	-2.82%	-21.57%	-	-	-
Total Shareholder Return	-0.03%	-2.82%	-21.57%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.